Digital innovation: „We change the way labs work“
QUDA – an in-house software – changes the way labs work. It increases our quality assurance and our drug saftey.
Search
Reimagining digital healthcare worldwide
How does our digital lab BI X innovate in Ingelheim and Shanghai? Read about success stories based on different ideation processes
Innovation through Collaboration
Pharmaceutical manufacturers and healthcare professionals regularly interact to learn from each other and improve patient care.
Boehringer Ingelheim Awards Innovation Prize to Ablevia
Innovative solution from Ablevia for rapid and selective elimination of harmful antibodies without impediment to the immune system
About Our Innovation Prize
Celebrating Our Innovation Prize Winners
Women in STEM: Passion for science to achieve more sustainable healthcare solutions
Women in STEM: Passion for science to achieve more sustainable healthcare solutions
Swine
Swine
Transforming pig farming: how AI helps detect respiratory disease in pigs and more
Transforming pig farming: how AI helps detect respiratory disease in pigs and more
Boehringer Ingelheim Office Hours 2024: Shaping the Future of Innovation in Europe
Boehringer Ingelheim is actively supporting the next generation of innovators.
Data Science: Revolutionizing research and development with data driven insights
Using data in pharmaceutical research to better address patient needs
Data Privacy
Data protection In an increasingly digitalized world, the effective protection of personal data and the privacy of each individual plays an increasingly important role. For this reason, on May 25, 2018, the new EU General Data Protection Regulation GDPR
Embracing diversity in clinical trials: A global mandate
Have you ever wondered why medicines work differently for different people? Each patient is unique. By embracing diversity in clinical trials, we enable more equitable and inclusive healthcare.
Venture Fund searching for groundbreaking trends
The Boehringer Ingelheim Venture Fund acquires minority stakes in biotech start-ups, and even supports the majority before and during their founding.
The global $1 trillion mental health problem needs more funding
Nearly one billion people around the world live with a mental health condition, yet an estimated 70% don’t have access to the help they need.
Mental Health
Boehringer Ingelheim has a range of different compounds in development for Central Nervous System (CNS) diseases, some in advanced clinical phases.
How Boehringer Ingelheim is Supporting Grass Roots Innovation
Our Grass Roots activities support life-science innovators with mentoring and networking opportunities
New cancer research building: Boosting innovation in oncology
With our new cancer research building in Vienna, we’ll advance our oncology pipeline and strengthen our commitment to innovation and collaboration.
Living and Working in Times of War - Employees from Ukraine Report
Living and Working in Times of War - Employees from Ukraine Report
Unleashing Innovation at Boehringer Ingelheim
Join us at our upcoming seminar and networking event where we'll share our unique approach to fostering innovation and supporting startups. We're excited to introduce you to Research Beyond Borders, our approach to open science: opnMe.com
Making a difference in clinical trials: The impact of engagement
We are partnering with patients, caregivers and trial site staff to design and conduct our clinical trials, to provide a better experience for all.
Making sustainable medicines through eco-design
Our goal is to minimize the environmental footprint of our medicines through integration of eco-design and green chemistry across the entire lifecycle
75 Years Boehringer Ingelheim in Austria
75 Years Boehringer Ingelheim in Austria
Boehringer Ingelheim Office Hours
Boehringer Ingelheim Office Hours
Cat vaccination ten things you should know
Find out how you can keep your feline companion happy and healthy. 10 important questions about cat vaccination to help you make informed decisions about maintaining your cat’s health.
Drug discovery Boehringer Ingelheim
Every day, scientists at Boehringer Ingelheim embark on a journey. It is a journey that can take up to 15 years and requires significant investment. Only a tiny proportion of these journeys are successful.